Abstract | BACKGROUND: METHOD: RESULTS/CONCLUSION: Since obesity seems to become a worldwide problem and given the low costs of generic pravastatin, it may even be cost-effectively used in developing countries.
|
Authors | Antonio Iglesias del Sol, Prabath W B Nanayakkara |
Journal | Expert opinion on drug metabolism & toxicology
(Expert Opin Drug Metab Toxicol)
Vol. 4
Issue 6
Pg. 821-5
(Jun 2008)
ISSN: 1742-5255 [Print] England |
PMID | 18611121
(Publication Type: Journal Article, Review)
|
Chemical References |
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Pravastatin
|
Topics |
- Atherosclerosis
(complications, drug therapy)
- Cardiovascular Diseases
(etiology, prevention & control)
- Evidence-Based Medicine
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(adverse effects, therapeutic use)
- Hypercholesterolemia
(complications, drug therapy)
- Practice Guidelines as Topic
- Pravastatin
(adverse effects, therapeutic use)
- Treatment Outcome
|